Having trouble accessing articles? Reset your cache.

GlaxoSmithKline preclinical data

Researchers at GlaxoSmithKline's Sirtris Pharmaceuticals Inc. subsidiary reported kinetic and biophysical data for 26 of its sirtuin 1 ( SIRT1)-activating compounds - including SRT1460, SRT1720 and SRT2183 - suggesting that the compounds interact directly

Read the full 340 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE